A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells

Focal adhesion kinase (FAK) hyperactivation is common in pancreatic ductal adenocarcinoma (PDAC). A small molecule, GSK2256098 (GlaxoSmithKline), has been developed to inhibit FAK activity through targeting the phosphorylation site of FAK, tyrosine (Y) 397. We sought to determine whether GSK2256098...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Cycle
Hlavní autoři: Zhang, Jianliang, He, Di-Hua, Zajac-Kaye, Maria, Hochwald, Steven N
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2014
Témata:
Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615113/
https://ncbi.nlm.nih.gov/pubmed/25486573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.949550
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky